Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Neuropharmacology|November 30, 2011
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapyRichard L Hauger, J Alberto Olivares-Reyes, Frank M Dautzenberg, et al.
Psychiatry Research|August 1, 1992
Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophreniaM F Egan, R S el-Mallakh, R L Suddath, et al.
Journal of Rehabilitation Research and Development|September 10, 2013
Veterans Health Administration vocational services for Operation Iraqi Freedom/Operation Enduring Freedom Veterans with mental health conditionsElizabeth W Twamley, Dewleen G Baker, Sonya B Norman, et al.
Endocrinology|September 10, 2024
Deletion of Nuclear Progesterone Receptors From Kisspeptin Cells Does Not Impair Negative Feedback in Female MiceKendra M Dillon, Dayanara B Lohr, Alyssa G Novak, et al.
Psychiatric Services (Washington, D.C.)|November 12, 2005
A randomized trial of short-term acute residential treatment for veteransWilliam B Hawthorne, Elizabeth E Green, Todd Gilmer, et al.
Schizophrenia Research|August 14, 2013
Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled studyJames B Lohr, Lianqi Liu, Michael P Caligiuri, et al.
Military Medicine|March 4, 2015
Differential impact of combat on postdeployment symptoms in female and male veterans of iraq and afghanistanNiloofar Afari, James Pittman, Elizabeth Floto, et al.
Annals of General Psychiatry|November 26, 2014
Pain sensitivity in posttraumatic stress disorder and other anxiety disorders: a preliminary case control studySheeva Mostoufi, Kathryn M Godfrey, Sandra M Ahumada, et al.
Human Psychopharmacology|July 12, 2012
Effects of anxiolytic treatment on potentiated startle during aversive image anticipationDean T Acheson, Murray B Stein, Martin P Paulus, et al.
Expert Opinion on Pharmacotherapy|January 26, 2006
Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicinesVural Ozdemir, Eleni Aklillu, Steven Mee, et al.
Pageof 12